(1)
Second-Generation Androgen Receptor Inhibitors in Therapy of Non-Metastatic Castration Resistant Prostate Cancer: Role of Safety Profile and Effect on Quality of Life. Вопр. онкол. 2022, 67 (2), 217-226. https://doi.org/10.37469/0507-3758-2021-67-2-217-226.